Health properties of milk fermented with Lactobacillus casei strain shirota (LcS)

Handbook of Fermented Functional Foods, Second Edition

Volumn , Issue , 2008, Pages 165-208

  Miyazaki, Kouji ^a   Matsuzaki, Takeshi ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID;

LACTIC ACID BACTERIA; LACTOBACILLUS CASEI; MEAT PRODUCTS;

FERMENTED MILK;

EID: 79551659449     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (91)

1. Salminen, S. and A. von Wright Eds., Lactic Acid Bacteria, Marcel Dekker, Inc., New York, 1993.
2. Stanier, R.Y., Doudoroff, M., and Adelberg, E.A., The Microbial World, Prentice-Hall, Inc., New York, 1957.
3. Tissier, H., Recherches sur La Flore Intestinale. Normale et Pathologique du Nourrisson., Georges Carre et C. Naud, Eds., 3 Paris, 1900.
4. Moro, E., Uber dienach Gram farbbaren Bacillen des Sauglingsstuhles, Wien. Klin. Wochenschr., 13, 114-115, 1900.
5. Orla-Jensen, S., The Lactic Acid Bacteria, Host, Copenhagen, Denmark, 1919, pp. 1-196.
6. Skerman, V.B.D., McGowan, V., and Sneath, P.H.A., Approved list of bacterial names, Int. J. Syst. Bacteriol., 30, 225-420, 1980.
7. Mitsuoka, T., Intestinal flora and animal models, in Proceedings of 2nd Symposium on Intestinal Flora: Intestinal Flora and Cancer, Part 2, Mitsuoka, T., Ed., Japan Scientific Societies Press, Tokyo, 1995, pp. 3-27.
8. Fuller, R., Robotics in man and animals, J. Appl. Bacteriol., 66, 365-378, 1989.
9. Guidelines for the evaluation of probiotics in food, Report of a joint FAO/WHO working group on dafting guidelines for evaluation of probiotics in food, 2002.
10. Gibson, G. R., and Roberfroid, M. B., Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics, J. Nutr., 125, 1401-1412, 1995.
11. Lactobacillus casei strain Shirota-Intestinal Flora and Human Health, Yakult Central Institute for Microbiological Research, Japan, 1999.
12. Ryter, A. and Kellenberger, E., Etude au microscope electronique de plasmas contenant de l’acide desoxyribonucleique. I. Les nucleoides des bacteries en croissance active, Z. Naturforsch., 136, 597, 1958.
13. Amako, K., Fine structure of bacteria, in Electron Micrographs of Bacteria, Amako, K., Ed., Nanzando, Tokyo, 1983, pp. 16-89.
14. Nagaoka, M., Muto, M., Nomoto, K., Matsuzaki, T., Watanabe, T., and Yokokura, T., Structure of polysaccharide-peptidoglycan complex from the cell wall of Lactobacillus casei YIT9018, J. Biochem., 108, 568-571, 1990.
15. Smith, J., Protein surface layers of bacteria, in Bacterial Outer Membranes as Model Systems, Inoue, M., Ed., John Wiley and Sons Ltd., New York, 1986, pp. 343-376.
16. Kaneko, T., Morita, H., Abe, T., Uchida, K., Yamamoto, N., and Morishita, T., Nutrition and metabolism of lactic acid bacteria, in Science and Technology of Lactic Acid Bacteria, Japanese Scientific Societies Press, Tokyo, 1996, pp. 89-132.
17. Shimizu-Kadota, M., Properties of lactose plasmid pLY101 in Lactobacillus casei, Appl. Envron. Microbiol., 53, 2987-2991, 1991.
18. Yamachita, T., Takahashi, Y., Usami, A, Takahashi, H., and Aso, K., Flavor producedduring lactic acid fermentation: part 1. Analysis of flavor factors, Annual Report of Yakult Central Institute for Microbiological Research, 2, 37-47, 1971.
19. Chang, I.S., Kim, B.H., and Shin, P.K., Use of sulfite and hydrogen peroxide to control bacterial contamination in ethanol fermentation, Appl. Environ. Microbiol., 63, 1-6, 1997.
20. Morishita, T., Fukuda, T., Shirota, T., and Yura, T., Genetic basis of nutritional requirements in Lactobacillus casei, J. Bacteriol., 120, 1078-1084, 1974.
21. Sato, T., Shirasawa, Y., Kiwaki, M., and Sato, S., Genome analyses of lactic acid bacteria and bifidobacteria: genome analyses of Lactobacillus casei and Bifidobacterium breve, J. Intes. Microbiol., 18, 135-140, 2004.
22. De Man, J.C., Rogosa, M., and Sharpe M. E., Medium for lactobacilli, J. Appl. Bacteriol., 23, 130-135, 1960.
23. Efthymiou, C. and Hansen, P.A., An antigenic analysis of Lactobacillus acidophilus, J. Infect. Dis., 110, 258-267, 1962.
24. Sansawa, H., Lactobacillus caseistrain Shirota-Intestinal Flora and Human Health, Yakult Central Institute for Microbiological Research, Japan, 1999, p. 94.
25. Kawami, K., Stability of Yakult beverage during storage, Reports on Yakult Beverage and Yakult Strain, No. 13, 1980.
26. Shelef, L.A. and Firstenberg-Eden, R., Novel selective and non-selective optical detection of microorganisms, Lett. Appl. Microbiol., 25, 202-206, 1997.
27. Kolars, J.C., Yogurt-An autodigesting source of lactose, The New Engl. J. Med., 310, 1-3, 1984.
28. Mayer, E.A., The physiology of gastric storage and emptying, in Physiology of the Gastrointestinal Tract, 3rd Ed., Raven Press, New York, 1994, pp. 929-976.
29. Ohashi, Y. and Umesaki, Y., Kinetics of L. casei strain Shirota fermented milk in upper intestinal tract of the rat model, Digestion Absorption, 20, 119-123, 1997.
30. Ohashi, Y., Inoue, R., Tanaka, K., Matsuki, T., Umesaki, Y., and Uchida, K., Lactobacillus casei strain Shirota-fermented milk stimulates indigenous Lactobacilli in the pig intestine, J. Nutri. Sci. Vitaminol., 47, 172-176, 2001.
31. Yokokura, T., Kato, I., and Mutai, M., Antitumor effect of Lactobacillus casei (LC9018), in Intestinal Flora and Carcinogenesis, Mitsuoka, T., Ed., Japan Scientific Societies Press, 1981, pp. 125-137.
32. Kato, I., Kobayashi, S., Yokokura, T., and Mutai., M., Antitumor activity of Lactobacillus casei in mice, Gann, 72, 517-523, 1981.
33. Matsuzaki, T., Matsuzaki, T., Yokokura, T., and Mutai., M., Antitumor effect of intrapleural administration of Lactobacillus casei in mice, Cancer Immunol. Immunother., 26, 209-214, 1988.
34. Takagi, A., Matsuzaki, T., Sato, M., Nomoto, K., Morotomi, M., and Yokokura, T., Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthreneinduced carcinogenesis in mice, Med. Microbiol. Immunol., 188, 111-116, 1999.
35. Matsuzaki, T., Tsukio, K., Yokokura, T., and Mutai, M., Effect of subcutaneous injection of a lactobacilli preparation, LC9018 and antitumor drugs on murine tumor, Biotherapy, 2, 440-445, 1988.
36. Matsuzaki, T., Yokokura, T., and Azuma, I., Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice, Cancer Immunol. Immunother., 24, 99-105, 1987.
37. Takagi, A., Matsuzaki, T., Sato, M., Nomoto, K., Morotomi, M., and Yokokura T., Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism, Carcinogenesis, 22, 599-605, 2001.
38. Yasutake, N., Kato, I., Ohwaki, M., Yokokura, T., and Mutai, M., Host-mediated antitumor activity of Lactobacillus casei in mice, Gann, 75, 72-80, 1984.
39. Yasutake, N., Ohwaki, M., Mutai, M., Koide, Y., and Yoshida, T., Anti-tumor effect of humoral and cellular immunities mediated by a bacterial immunpopotentiator, Lactobacillus casei, in mice, Cancer Immunol. Immunother., 20, 109-116, 1985.
40. Matsuzaki, T., Yokokura, T., and Azuma, I., Antitumor-activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pig, Cancer Immunol. Immunother., 20, 18-22, 1985.
41. Matsuzaki, T., Shimizu, Y., and Yokokura, T., Augmentation of antimetastatic effect on Lewis lung carcinoma (3LL) in C57BL/6 mice by priming with Lactobacillus casei, Med. Microbiol. Immunol., 179, 161-168, 1990.
42. Miake, S., Nomoto, K., Yokokura, T., Yoshikai, Y., Mutai, M., and Nomoto, K., Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice, Infect. Immun., 48, 480-485, 1985.
43. Dalton, C.B., Austin, C.C., Sobel, J., Hayes, P.S., Bibb, W.F., Graves, L.M., Swaminathan, B., Proctor, M.E., and Griffin, P.M., An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk, N. Engl. J. Med., 336, 100-105, 1997.
44. Nomoto, K., Miake, S., Hashimoto, S., Yokokura, T., Mutai, M., Yoshikai, Y., and Nomoto, K., Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei, J. Clin. Lab. Immunol., 17, 91-97, 1985.
45. Ogawa, M., Shimizu, K., Nomoto, K., Takahashi, M., Watanuki, M., Tanaka, R., Tanaka, T., Hamabata, T., Yamasaki, S., and Takeda, Y., Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits, Infect. Immun., 69, 1101-1108, 2001.
46. Hori, T., Kiyoshima, J., Shida, K., and Yasui, H., Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota, Clin. Diagn. Lab. Immunol., 9, 105-108, 2002.
47. Yasui, H., Kiyoshima, J., and Hori, T., Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota, Clin. Diagn. Lab. Immunol., 11, 675-679, 2004.
48. Furushiro, M., Hashimoto, S., Hamura, M., and Yokokura, T., Mechanism of the antihypertensive effect of a polysaccharide-glycopeptide complex from Lactobacillus casei in spontaneously hypertensive rats (SHR), Biosci. Biotech. Biochem., 57, 978-981, 1993.
49. Furushiro, M., Sawada, S., Hirai, K., Motoike, M., Sansawa, H., Kobayashi, S., Watanuki, M., and Yokokura, T., Blood pressure-lowering effect of extract from Lactobacillus casei in spontaneously hypertensive rats (SHR), Agri. Biol. Chem., 54, 2193-2198, 1990.
50. Shida, K., Makino, K., Morishita, A., Takamizawa, K., Hachimura, S., Ametani, A., Sato, T., Kumagai, Y., Habu, S., and Kaminogawa, S., Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocytes cultures, Int. Arch. Allergy Immunol., 115, 278-287, 1998.
51. Matsuzaki, T., Yamazaki, R., Hashimoto, S., and Yokokura, T., Effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice, J. Dairy Sci., 81, 48-53, 1988.
52. Shida, K., Takahashi, R., Iwadate, E., Takamizawa, K., Yasui, H., Sato, T., Habu, S., Hachimura, S., and Kaminogawa, S., Lactobacillus caseistrain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model, Clin. Exp. Allergy, 32, 563-570, 2002.
53. Matsuzaki, T., Nagata, Y., Kado, S., Uchida, K., Kato, I., Hashimoto, S., and Yokokura, T., Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei, APMIS, 105, 643-649, 1997.
54. Mike, A., Nagaoka, N., Tagami, Y., Miyashita, M., Shimada, S., Uchida, K., Nanno, M., and Ohwaki, M., Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactobacillus casei in MRL/lpr mice, Clin. Exp. Immunol., 117, 368-375, 1999.
55. Kato, I., Endo-Tanaka, K., and Yokokura, T., Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice, Life Sci., 63, 635-644, 1998.
56. Matsumoto, S., Hara, T., Hori, T., Mitsuyama, K., Nagaoka, M., Tomiyasu, N., Suzuki, A., and Sata, M., Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of proinflammatory cytokines in lamina propria mononuclear cells, Clin. Exp. Immunol., 140, 417-426, 2005.
57. Aritaki, S. and Ishikawa, S., Application of milk fermented by L. acidophilus in the pediatric field, J. Jpn. Prediatr. Soc., 66, 125-130, 1962.
58. Yamagishi, T., Serikawa, T., Morita, R., Takahashi, K., and Nishida, S., Effect of a Lactobacillus product administration on the anaerobic intestinal flora of aged adults, Jpn. J. Microbiol., 18, 211-216, 1974.
59. Shirota, M., Aso, K., and Iwabuchi, A., Studies on microflora of the human intestine. I. Alteration of the constitution of intestinal flora by oral administration of L. acidophilus strain Shirota to healthy infants, Jpn. J. Bacteriol., 21, 274-283, 1966.
60. Hanada, K., Kondo, F., Kitahara, R., Tokushige, H., Ueno, T., Kutani, T., and Ochiai, K., Effect of daily administration of Lactobacillus fermented milk on children, J. Kobe Institute Health, 55-60, 1956.
61. Tanaka, R., Tohyama, K., Morotomi, M., Takayama, H., Nanno, M., Kuroshima, T., and Mutai, M., Effect onthe fecal flora and urinary metabolites of the administration of Lactobacillus casei and Bifidobacterium breve, in Proceeding of I RIKEN Symposium on Intestinal Flora: Intestinal Flora and Cancer, Mitsuoka, T., Ed., Japan Scientific Societies Press, Tokyo, 1981, pp. 79-103.
62. Tanaka, R. and Ohwaki, M., A controlled study of the effects of the ingestion of Lactobacillus casei-fermented milk on the intestinal microflora, its microbial metabolism and the immune system of healthy humans, in Proceeding of XII RIKEN Symposium on Intestinal Flora: Intestinal Flora and Diet, Mitsuoka, T., Ed., Japan Scientific Societies Press, Tokyo, 1993, pp. 85-104.
63. Spanhaak, S., Havenaar, R., and Schaafsma, G., The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans, Eur. J. Clin. Nutr., 52, 899-907, 1998.
64. Winkelstein, A., Lactobacillus acidophilus tablets in the therapy of various intestinal disorders: a preliminary report, Am. Proct. Dig. Treat., 1, 1637-1639, 1955.
65. Kawamura, T., Ohnuki, K., and Ichida, F., Clinical study of BLG-01 containing Lactobacillus casei: effect on irregular bowel movements and abdominal discomfort, Jpn. Pharmacol. Ther., 9, 4361-4370, 1981.
66. Koebnick, C., Wagner, I., Leitzmann, P., Stern, U., and Zunft, H. J., Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation, Can. J. Gastroenterol., 17, 655-659, 2003.
67. Matsumoto, K., Takada, T., Shimizu, K., Kado, Y., Kawakami, K., Makino, I., Yamaoka, Y., Hirano, K., Nishimura, A., Kajimoto, O., and Nomoto, K., The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study, Biosci. Microflora, 25, 39-48, 2006.
68. Tohyama, K., Kobayashi, Kan, T., Yazawa, K., Terashima, T., and Mutai, M., Effect of lactobacilli on urinary indican excretion in gnotobiotic rats and in man, Microbiol. Immun., 25, 101-112, 1981.
69. De Preter, V., Geboes, K., Verbrugghe, K., De Vuyst, L., Vanhoutte, T., Huys, G., Swings, J., Pot, B., and Verbeke, K., The invivo use of the stable isotope-labelled biomarkers lactose-[15N]ureide and [2H4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers, Br. J. Nutr., 92, 439-446, 2004.
70. Okawa, T., Kita, M., Arai, T., Iida, K., Dokiya, T., Takegawa, Y., Hirokawa, Y., Yamazaki, K., and Hashimoto, S., Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of the uterine cervix. Its effect on tumor reduction and histology, Cancer, 64, 1769-1776, 1989.
71. Masuno, T., Kishimoto, S., Ogura, T., Honma, T., Niitani, H., Fukuoka, M., and Ogawa, A., Comparative trial of LC 9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer, Cancer, 68, 1495-1500, 1991.
72. Okawa, T., Niibe, H., Arai, T., Sekiba, K., Noda, K., Takeuchi, S., Hashimoto, S., and Ogawa, N., Effect of LC 9018 combined with radiation therapy on carcinoma of the uterine cervix, Cancer, 72, 1949-1954, 1993.
73. Aso, Y., Akaza, H., and theBLP study Group, Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer, Urol. Int., 49, 125-129, 1992.
74. Aso, Y., Akaza, H., Tsukamoto, T., Imai, K., Naito, S., and theBLP Study Group, Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trail, Eur. Urol., 27, 104-109, 1995.
75. Ohashi, Y., Nakai, S., Tsukamoto, T., Masumori, N., Akaza, H., Miyanaga, N., Kitamura, T., Kawabe, K., Kotake, T., Kuroda, M., Naito, S., Koga, H., Saito, Y., Nomata, K., Kitagawa, M., and Aso, Y., Habitual intake of lactic acid bacteria and risk reduction of bladder cancer, Urol. Int., 68, 273-280, 2002.
76. Ishikawa, H., Akedo, I., Otani, T., Suzuki, T., Nakamura, T., Takeyama, I., Ishiguro, S., Miyaoka, E., Sobue, T., and Kakizoe, T., Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors, Int. J. Cancer, 116, 762-767, 2005.
77. Sawamura, A., Yamaguchi, Y., Tohge, T., Nagata, N., Ikeda, H., Nakanishi, K., and Asakura, S., Enhancement of immuno-activities by oral administration of Lactobacillus casei in colorectal cancer patients, Biotherapy, 8, 1567-1572, 1994.
78. Nagao, F., Nakayama, M., Muto, T., and Okumura, K., Effects of fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects, Biosci. Biotechnol. Biochem., 64, 2706-2708, 2000.
79. Morimoto, K., Takeshita, T., Nanno, M., Tokudome, S., and Nakayama, K., Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers, Prev. Med., 40, 589-594, 2005.
80. Matsuzaki, T., Saito, M., Usuku, K., Nose, H., Izumo, S., Arimura, K., and Osame, M., A prospectiveuncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis, J. Neurol. Sci., 237, 75-81, 2005.
81. Imai, K., Matsuyama, S., Miyake, S., Suga, K., and Nakachi, K., Natural cytotoxicactivity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population, Lancet, 356, 1795-1799, 2000.
82. Candy, D. C., Densham, L., Lamont, L. S., Greig, M., Lewis, J., Bennett, H., and Griffiths, M. J., Effect of administration of Lactobacillus casei shirota on sodium balance in an infant with short bowel syndrome, Pediatr. Gastroenterol. Nutr., 32, 506-508, 2001.
83. Kanamori, Y., Hashizume, K., Sugiyama, M., Morotomi, M., and Yuki, N., Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure, Dig. Dis. Sci., 46, 2010-2016, 2001.
84. Kanamori, Y., Hashizume, K., Sugiyama, M., Mortomi, M., Yuki, N., and Tanaka, R., A novelsynbiotic therapy dramatically improved the intestinal function of a pediatric patient with laryngotracheo-esophageal cleft (LTEC) in the intensive care unit, Clin. Nutr., 21, 527-530, 2002.
85. Kanamori, Y., Hashizume, K., Kitano, Y., Tanaka, Y., Morotomi, M., Yuki, N., and Tanaka, R., Anaerobic dominant flora was reconstructed by synbiotics in an infant with MRSA enteritis, Pediatr. Int., 45, 359-362, 2003.
86. Kanamori, Y., Sugiyama, M., Hashizume, K., Yuki, N., Morotomi, M., and Tanaka, R., Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis, J. Pediatr. Surg., 39, 1686-1692, 2004.
87. Kanazawa, H., Nagino, M., Kamiya, S., Komatsu, S., Mayumi, T., Takagi, K., Asahara, T., Nomoto, K., Tanaka, R., and Nimura, Y., Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy, Langenbecks Arch. Surg., 390, 104-113, 2005.
88. Sugawara, G., Nagino, M., Arai, T., Nishio, H., Ebata, T., Takagi, K., Ueyama, J., Suzuki, T., Takagi, K., Asahara, T., Nomoto, K., Tanaka, R. and Nimura, Y., Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial, Ann. Surg. 244, 706-714, 2006.
89. Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., and Jarvinen, A., Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG, Clin. Infect. Dis., 38, 62-69, 2004.
90. Asahara, T., Takahashi, M., Nomoto, K., Takayama, H., Onoue, M., Morotomi, M., Tanaka, R., Yokokura, T., and Yamashita, N., Assessment of safety of Lactobacillus strains based on resistance to host innate defense mechanisms, Clin. Diagn. Lab. Immunol., 10, 169-173, 2003.
91. Srinivasan, R., Meyer, R., Padmanabhan, R., and Britto, J., Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children, J. Pediatr. Gastroenterol. Nutr., 42, 171-173, 2006.